These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 6139453)

  • 21. Reversal of 5HT-induced bronchoconstriction by PGI2: distribution of central and peripheral actions.
    Spannhake EW; Levin JL; Mellion BT; Gruetter CA; Hyman AL; Kadowitz PJ
    J Appl Physiol Respir Environ Exerc Physiol; 1980 Sep; 49(3):521-7. PubMed ID: 7009520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular actions of prostacyclin (PGI2) in the cat.
    Lippton HL; Paustian PW; Mellion BT; Nelson PK; Feigen LP; Chapnick BM; Hyman AL; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):121-30. PubMed ID: 393193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purification.
    Wong PY; Lee WH; Chao PH; Reiss RF; McGiff JC
    J Biol Chem; 1980 Oct; 255(19):9021-4. PubMed ID: 6997309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets.
    Eggerman TL; Andersen NH; Robertson RP
    J Pharmacol Exp Ther; 1986 Mar; 236(3):568-73. PubMed ID: 2869139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin concentrations in ovine maternal and fetal tissues at late gestation.
    Olson DM; Lye SJ; Challis JR
    Pediatr Res; 1986 Jan; 20(1):83-6. PubMed ID: 3456149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary and systemic vascular effects of exogenous prostaglandin I2 in fetal lambs.
    Leffler CW; Hessler JR
    Eur J Pharmacol; 1979 Feb; 54(1-2):37-42. PubMed ID: 369870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of prostacyclin involvement in angiotensin-induced aldosterone secretion in rat adrenal cells.
    Campbell WB; Gomez-Sanchez CE
    Endocrinology; 1985 Jul; 117(1):279-86. PubMed ID: 3924581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin-related renin release from rabbit renal cortical slices.
    Spokas EG; Wong PY; McGiff JC
    Hypertension; 1982; 4(3 Pt 2):96-100. PubMed ID: 7040243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of endogenous prostaglandins in salt-induced hypertension.
    Ogihara T; Gotoh S; Tabuchi Y; Kumahara Y
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):114-8. PubMed ID: 3881881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
    Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of fibrinolytic activity in human skin fibroblasts by prostaglandins E1, E2 and I2.
    Crutchley DJ; Conanan LB; Maynard JR
    J Pharmacol Exp Ther; 1982 Sep; 222(3):544-9. PubMed ID: 7050342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
    Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
    Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiopulmonary actions of prostaglandin 6-keto-E1 in the anesthetized dog.
    Nandiwada P; Hyman AL; Feigen LP; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1980 May; 245(1):118-28. PubMed ID: 7190813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of PGE1, PGE2 and PGI2 on ventricular arrhythmias during myocardial infarction in conscious dogs: relation to infarct size.
    Jugdutt BI
    Prostaglandins Med; 1981 Nov; 7(5):431-55. PubMed ID: 6798589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of prostacyclin: formation of an active metabolite in the liver.
    Wong PY; Lee WH; Quilley CP; McGiff JC
    Fed Proc; 1981 May; 40(7):2001-4. PubMed ID: 7014260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pertussis toxin abolishes the inhibitory effects of prostaglandins E1, E2, I2 and F2 alpha on hormone-induced cAMP accumulation in cultured hepatocytes.
    Melien O; Winsnes R; Refsnes M; Gladhaug IP; Christoffersen T
    Eur J Biochem; 1988 Mar; 172(2):293-7. PubMed ID: 2832160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypotensive and renovascular actions of 6-keto-prostaglandin E1, a metabolite of prostacyclin.
    Quilley CP; Wong PY; McGiff JC
    Eur J Pharmacol; 1979 Aug; 57(2-3):273-6. PubMed ID: 385331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease.
    Li SR; Yang Q; Koller E; Kurtaran A; Bischof C; Leimer M; Rauscha F; Pidlich J; Virgolini I
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2066-73. PubMed ID: 9351373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6-Keto-prostaglandin E1 and the decidual cell reaction in rats.
    Doktorcik PE; Kennedy TG
    Prostaglandins; 1986 Nov; 32(5):679-89. PubMed ID: 3469690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of prostaglandin E2, I2 and F2 alpha on systemic and renal hemodynamics, renal function and renin secretion in anesthetized dogs.
    Hashimoto T
    Jpn J Pharmacol; 1980 Apr; 30(2):173-86. PubMed ID: 7005498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.